AUROBINDO PHARMA LTD vs Max Healthcare Institute Limited
A side-by-side comparison of AUROBINDO PHARMA LTD (AUROPHARMA) and Max Healthcare Institute Limited (MAXHEALTH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, AUROBINDO PHARMA LTD leads AUROPHARMA vs MAXHEALTH on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["The company has delivered a poor sales growth of 6.32% over past five years.", "Company has a low return on equity of 10.8% over last 3 years.", "Company might be capitalizing the interest cost"]
- − ["Stock is trading at 9.78 times its book value", "Tax rate seems low", "Company has a low return on equity of 13.7% over last 3 years.", "Company might be capitalizing the interest cost", "Dividend payout has been low at 13.6% of profits over last 3 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.